News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Worried About Johnson & Johnson (JNJ)'s Valuation? Consider This Crazy, Undervalued, 4.2% Yielding Pharmaceutical Stock Instead



3/30/2017 7:40:23 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
When it comes to blue chip dividend growth stocks, they don't get any better than Johnson & Johnson (NYSE:JNJ), whose 54 consecutive years of dividend growth makes it both a Dividend King and a true "buy and hold forever" stock.

Best of all, despite weak 2016 sales growth, the company continues to make all the right moves to ensure that its legendary dividend growth prowess continues for decades to come.

Read at Seeking Alpha


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES